<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Brainstorm Cell Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Brainstorm Cell Therapeutics Inc.

    BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Chaim Lebovits
    • FOUNDED
      2004
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in ...

    CNS Pharmaceuticals is a pre-clinical stage bio...

    Amount Raised:    $628,558
    Fundraising Status:    EC
    Filing Type:    CF
    Apyx Medical Corporation

    Apyx Medical Corporation

    Apyx™ Medical Corporation (formerly known as Bovie® Medical Corporation) is an ...

    Apyx™ Medical Corporation (formerly known as ...

    Filing Type:    PU
    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device compan...

    Cardiovascular Systems, Inc., based in St. Paul...

    Filing Type:    PU
    Surmodics, Inc.

    Surmodics, Inc.

    Following two acquisitions of Creagh Medical and NorMedix – recognized innovator...

    Following two acquisitions of Creagh Medical an...

    Filing Type:    PU
    Sientra, Inc.

    Sientra, Inc.

    Headquartered in Santa Barbara, California, Sientra is a diversified global medica...

    Headquartered in Santa Barbara, California, Sie...

    Filing Type:    PU
    CHF Solutions, Inc.

    CHF Solutions, Inc.

    CHF Solutions is focused on improving the quality of life for patients suffering f...

    CHF Solutions is focused on improving the quali...

    Filing Type:    PU
    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics Inc. is a clinical-stage biotherapy company using placental...

    Pluristem Therapeutics Inc. is a clinical-stage...

    Filing Type:    PU
    Caladrius Biosciences, Inc.

    Caladrius Biosciences, Inc.

    Caladrius is a clinical-stage biopharmaceutical company committed to the developme...

    Caladrius is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Histogenics Corporation

    Histogenics Corporation

    Histogenics historically focused on the development of restorative cell therapies,...

    Histogenics historically focused on the develop...

    Filing Type:    PU
    Cortexyme, Inc.

    Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...

    Cortexyme is a biopharmaceutical company develo...

    Filing Type:    PU
    WindowMirror Inc

    WindowMirror Inc

    WindowMirror's BUTTERFLY will be a collaborative SaaS (Software as a Service) plat...

    WindowMirror's BUTTERFLY will be a collaborativ...

    Amount Raised:    $14,462.00
    Fundraising Status:    EC
    Filing Type:    CF
    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...

    Intra-Cellular Therapies is a biopharmaceutical...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.